GeneDx Holdings Corp. Sued for Securities Law Violations
Investors are urged to contact DJS Law Group regarding a class action lawsuit filed against GeneDx Holdings Corp. for alleged violations of securities laws.
The DJS Law Group, representing investors, has announced a class action lawsuit against GeneDx Holdings Corp. (NASDAQ: WGS). The suit alleges that GeneDx violated federal securities laws, including Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5.
The lawsuit pertains to investors who purchased GeneDx stock between April 16, 2025, and May 4, 2026. According to the complaint, the company made false and misleading statements to the market. Specifically, GeneDx experienced a drop in its adjusted gross margin in the first quarter of 2026 and subsequently lowered its full-year earnings projections.
Shareholders who purchased WGS stock during this class period are encouraged to contact the firm. The deadline to participate is August 3, 2026. While not required to share in any recovery, becoming a lead plaintiff can influence the litigation.
GeneDx Holdings Corp. offers genetic testing services. The alleged misrepresentations led to a decline in the company's stock price, causing financial losses for investors who relied on the company's public statements regarding its financial performance and outlook.